---
figid: PMC11214300__gr4
pmcid: PMC11214300
image_filename: gr4.jpg
figure_link: /pmc/articles/PMC11214300/figure/fig0004/
number: Fig. 4
figure_title: ''
caption: Nanoparticle and nanocarrier-based drug delivery for diabetes and related
  conditions targeting autophagy and mitophagy. (A) hU-MSC-Derived Exosomes enhance
  insulin sensitivity in insulin-resistant adipocytes through the regulation of SIRT1,
  Adn and Leptin. (B) PEGylated liposomes containing aFGF, delivered using UTMD, activate
  the Akt pathway, inhibit GSK-3Î²1, and increase Nrf2, NOQ1 and SOD2 expression to
  protect against oxidative-stress induced damage.
article_title: 'Autophagy and mitophagy as potential therapeutic targets in diabetic
  heart condition: Harnessing the power of nanotheranostics.'
citation: Sagnik Nag, et al. Asian J Pharm Sci. 2024 Jun;19(3):100927.
year: '2024'

doi: 10.1016/j.ajps.2024.100927
journal_title: Asian Journal of Pharmaceutical Sciences
journal_nlm_ta: Asian J Pharm Sci
publisher_name: Shenyang Pharmaceutical University

keywords:
- Autophagy
- Diabetes
- Diabetic heart condition
- Mitophagy
- Nanotheranostics
- Nanomedicine

---
